CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −183 | $603.89 | $111K | 324,603 |
| 2026-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $605.33 | $24K | 324,563 |
| 2026-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $606.92 | $49K | 324,483 |
| 2026-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $608.05 | $24K | 324,443 |
| 2026-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 119,410 | ||
| 2026-10-29 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-10-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −53 | $590.43 | $31K | 333,890 |
| 2026-10-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,104 | $591.90 | $653K | 332,786 |
| 2026-10-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,563 | $592.97 | $927K | 331,223 |
| 2026-10-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,540 | $593.88 | $915K | 329,683 |
| 2026-10-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,248 | $594.89 | $742K | 328,435 |
| 2026-10-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,678 | $595.88 | $1000K | 326,757 |
| 2026-10-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,355 | $596.86 | $809K | 325,402 |
| 2026-10-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −919 | $597.66 | $549K | 324,483 |
| 2026-10-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $599.30 | $24K | 324,443 |
| 2026-10-29 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 128,910 | ||
| 2026-10-28 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-10-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −821 | $583.50 | $479K | 333,122 |
| 2026-10-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,625 | $584.43 | $1.5M | 330,497 |
| 2026-10-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,902 | $585.36 | $1.1M | 328,595 |
Page 10 of 64 · 1,267 trades